nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Prazosin—SLC22A3—germ cell cancer	0.0512	1	CrCbGaD
Alfuzosin—Neuralgia—Ifosfamide—germ cell cancer	0.015	0.0158	CcSEcCtD
Alfuzosin—Ventricular arrhythmia—Ifosfamide—germ cell cancer	0.0141	0.0148	CcSEcCtD
Alfuzosin—Cholestasis—Ifosfamide—germ cell cancer	0.0137	0.0145	CcSEcCtD
Alfuzosin—Liver injury—Cisplatin—germ cell cancer	0.0107	0.0113	CcSEcCtD
Alfuzosin—Ventricular tachycardia—Ifosfamide—germ cell cancer	0.0104	0.011	CcSEcCtD
Alfuzosin—Injury—Bleomycin—germ cell cancer	0.00963	0.0102	CcSEcCtD
Alfuzosin—Cardiovascular disorder—Etoposide—germ cell cancer	0.00937	0.00988	CcSEcCtD
Alfuzosin—Arthritis—Bleomycin—germ cell cancer	0.00911	0.0096	CcSEcCtD
Alfuzosin—Hepatocellular injury—Cisplatin—germ cell cancer	0.00899	0.00947	CcSEcCtD
Alfuzosin—Angina pectoris—Vinblastine—germ cell cancer	0.00883	0.0093	CcSEcCtD
Alfuzosin—Neuropathy—Cisplatin—germ cell cancer	0.00844	0.00889	CcSEcCtD
Alfuzosin—Atrial fibrillation—Ifosfamide—germ cell cancer	0.00799	0.00842	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Vinblastine—germ cell cancer	0.00792	0.00835	CcSEcCtD
Alfuzosin—Neuropathy—Etoposide—germ cell cancer	0.00773	0.00815	CcSEcCtD
Alfuzosin—Osteoarthritis—Ifosfamide—germ cell cancer	0.00757	0.00798	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Dactinomycin—germ cell cancer	0.00744	0.00784	CcSEcCtD
Alfuzosin—Pharyngitis—Vinblastine—germ cell cancer	0.0072	0.00759	CcSEcCtD
Alfuzosin—Breast disorder—Ifosfamide—germ cell cancer	0.00684	0.00721	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Ifosfamide—germ cell cancer	0.00681	0.00718	CcSEcCtD
Alfuzosin—Angina pectoris—Ifosfamide—germ cell cancer	0.00637	0.00672	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00596	0.00628	CcSEcCtD
Alfuzosin—Breast disorder—Cisplatin—germ cell cancer	0.0059	0.00621	CcSEcCtD
Alfuzosin—Ill-defined disorder—Vinblastine—germ cell cancer	0.00586	0.00617	CcSEcCtD
Alfuzosin—Infestation NOS—Ifosfamide—germ cell cancer	0.00583	0.00615	CcSEcCtD
Alfuzosin—Infestation—Ifosfamide—germ cell cancer	0.00583	0.00615	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Ifosfamide—germ cell cancer	0.00572	0.00603	CcSEcCtD
Alfuzosin—Malaise—Vinblastine—germ cell cancer	0.00569	0.006	CcSEcCtD
Alfuzosin—Flushing—Bleomycin—germ cell cancer	0.00569	0.00599	CcSEcCtD
Alfuzosin—Vertigo—Vinblastine—germ cell cancer	0.00567	0.00598	CcSEcCtD
Alfuzosin—Pharyngitis—Dactinomycin—germ cell cancer	0.00567	0.00598	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Ifosfamide—germ cell cancer	0.00552	0.00581	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Etoposide—germ cell cancer	0.00538	0.00567	CcSEcCtD
Alfuzosin—Discomfort—Vinblastine—germ cell cancer	0.00531	0.0056	CcSEcCtD
Alfuzosin—Flushing—Dactinomycin—germ cell cancer	0.0053	0.00559	CcSEcCtD
Alfuzosin—Urinary tract disorder—Ifosfamide—germ cell cancer	0.00517	0.00545	CcSEcCtD
Alfuzosin—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00514	0.00542	CcSEcCtD
Alfuzosin—Urethral disorder—Ifosfamide—germ cell cancer	0.00513	0.00541	CcSEcCtD
Alfuzosin—Thrombocytopenia—Vinblastine—germ cell cancer	0.00505	0.00532	CcSEcCtD
Alfuzosin—Ill-defined disorder—Bleomycin—germ cell cancer	0.00495	0.00521	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Cisplatin—germ cell cancer	0.00493	0.00519	CcSEcCtD
Alfuzosin—Eye disorder—Ifosfamide—germ cell cancer	0.00489	0.00516	CcSEcCtD
Alfuzosin—Flushing—Ifosfamide—germ cell cancer	0.00486	0.00512	CcSEcCtD
Alfuzosin—Cardiac disorder—Ifosfamide—germ cell cancer	0.00486	0.00512	CcSEcCtD
Alfuzosin—Malaise—Bleomycin—germ cell cancer	0.00481	0.00507	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Cisplatin—germ cell cancer	0.00475	0.00501	CcSEcCtD
Alfuzosin—Angiopathy—Ifosfamide—germ cell cancer	0.00475	0.00501	CcSEcCtD
Alfuzosin—Mediastinal disorder—Ifosfamide—germ cell cancer	0.00472	0.00497	CcSEcCtD
Alfuzosin—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00461	0.00486	CcSEcCtD
Alfuzosin—Infestation NOS—Etoposide—germ cell cancer	0.00461	0.00485	CcSEcCtD
Alfuzosin—Infestation—Etoposide—germ cell cancer	0.00461	0.00485	CcSEcCtD
Alfuzosin—Mental disorder—Ifosfamide—germ cell cancer	0.00459	0.00483	CcSEcCtD
Alfuzosin—Chest pain—Bleomycin—germ cell cancer	0.00454	0.00479	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Etoposide—germ cell cancer	0.00451	0.00476	CcSEcCtD
Alfuzosin—Jaundice—Etoposide—germ cell cancer	0.00449	0.00473	CcSEcCtD
Alfuzosin—Discomfort—Bleomycin—germ cell cancer	0.00449	0.00473	CcSEcCtD
Alfuzosin—Malaise—Dactinomycin—germ cell cancer	0.00448	0.00473	CcSEcCtD
Alfuzosin—Urinary tract disorder—Cisplatin—germ cell cancer	0.00446	0.0047	CcSEcCtD
Alfuzosin—Connective tissue disorder—Cisplatin—germ cell cancer	0.00444	0.00467	CcSEcCtD
Alfuzosin—Urethral disorder—Cisplatin—germ cell cancer	0.00442	0.00466	CcSEcCtD
Alfuzosin—Constipation—Vinblastine—germ cell cancer	0.00441	0.00464	CcSEcCtD
Alfuzosin—Pain—Vinblastine—germ cell cancer	0.00441	0.00464	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Etoposide—germ cell cancer	0.00436	0.00459	CcSEcCtD
Alfuzosin—Oedema—Bleomycin—germ cell cancer	0.00435	0.00459	CcSEcCtD
Alfuzosin—Infection—Bleomycin—germ cell cancer	0.00432	0.00456	CcSEcCtD
Alfuzosin—Thrombocytopenia—Bleomycin—germ cell cancer	0.00426	0.00449	CcSEcCtD
Alfuzosin—Feeling abnormal—Vinblastine—germ cell cancer	0.00425	0.00448	CcSEcCtD
Alfuzosin—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00423	0.00446	CcSEcCtD
Alfuzosin—Eye disorder—Cisplatin—germ cell cancer	0.00422	0.00445	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00421	0.00444	CcSEcCtD
Alfuzosin—Cardiac disorder—Cisplatin—germ cell cancer	0.00419	0.00442	CcSEcCtD
Alfuzosin—Flushing—Cisplatin—germ cell cancer	0.00419	0.00442	CcSEcCtD
Alfuzosin—Discomfort—Dactinomycin—germ cell cancer	0.00418	0.00441	CcSEcCtD
Alfuzosin—Angioedema—Ifosfamide—germ cell cancer	0.00416	0.00439	CcSEcCtD
Alfuzosin—Malaise—Ifosfamide—germ cell cancer	0.00411	0.00433	CcSEcCtD
Alfuzosin—Vertigo—Ifosfamide—germ cell cancer	0.00409	0.00432	CcSEcCtD
Alfuzosin—Urinary tract disorder—Etoposide—germ cell cancer	0.00408	0.0043	CcSEcCtD
Alfuzosin—Abdominal pain—Vinblastine—germ cell cancer	0.00407	0.00429	CcSEcCtD
Alfuzosin—Mediastinal disorder—Cisplatin—germ cell cancer	0.00407	0.00429	CcSEcCtD
Alfuzosin—Hypotension—Bleomycin—germ cell cancer	0.00407	0.00429	CcSEcCtD
Alfuzosin—Oedema—Dactinomycin—germ cell cancer	0.00406	0.00428	CcSEcCtD
Alfuzosin—Urethral disorder—Etoposide—germ cell cancer	0.00405	0.00427	CcSEcCtD
Alfuzosin—Infection—Dactinomycin—germ cell cancer	0.00403	0.00425	CcSEcCtD
Alfuzosin—Palpitations—Ifosfamide—germ cell cancer	0.00403	0.00424	CcSEcCtD
Alfuzosin—Thrombocytopenia—Dactinomycin—germ cell cancer	0.00397	0.00419	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00397	0.00418	CcSEcCtD
Alfuzosin—Chest pain—Ifosfamide—germ cell cancer	0.00388	0.00409	CcSEcCtD
Alfuzosin—Arthralgia—Ifosfamide—germ cell cancer	0.00388	0.00409	CcSEcCtD
Alfuzosin—Eye disorder—Etoposide—germ cell cancer	0.00386	0.00407	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00385	0.00406	CcSEcCtD
Alfuzosin—Flushing—Etoposide—germ cell cancer	0.00384	0.00404	CcSEcCtD
Alfuzosin—Cardiac disorder—Etoposide—germ cell cancer	0.00384	0.00404	CcSEcCtD
Alfuzosin—Discomfort—Ifosfamide—germ cell cancer	0.00383	0.00404	CcSEcCtD
Alfuzosin—Angiopathy—Etoposide—germ cell cancer	0.00375	0.00395	CcSEcCtD
Alfuzosin—Mediastinal disorder—Etoposide—germ cell cancer	0.00373	0.00393	CcSEcCtD
Alfuzosin—Pain—Bleomycin—germ cell cancer	0.00372	0.00392	CcSEcCtD
Alfuzosin—Oedema—Ifosfamide—germ cell cancer	0.00372	0.00392	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.0037	0.0039	CcSEcCtD
Alfuzosin—Asthenia—Vinblastine—germ cell cancer	0.0037	0.0039	CcSEcCtD
Alfuzosin—Infection—Ifosfamide—germ cell cancer	0.0037	0.00389	CcSEcCtD
Alfuzosin—Nervous system disorder—Ifosfamide—germ cell cancer	0.00365	0.00384	CcSEcCtD
Alfuzosin—Ill-defined disorder—Cisplatin—germ cell cancer	0.00365	0.00384	CcSEcCtD
Alfuzosin—Thrombocytopenia—Ifosfamide—germ cell cancer	0.00364	0.00384	CcSEcCtD
Alfuzosin—Skin disorder—Ifosfamide—germ cell cancer	0.00361	0.00381	CcSEcCtD
Alfuzosin—Hyperhidrosis—Ifosfamide—germ cell cancer	0.0036	0.00379	CcSEcCtD
Alfuzosin—Feeling abnormal—Bleomycin—germ cell cancer	0.00359	0.00378	CcSEcCtD
Alfuzosin—Osteoarthritis—Methotrexate—germ cell cancer	0.00358	0.00377	CcSEcCtD
Alfuzosin—Malaise—Cisplatin—germ cell cancer	0.00354	0.00373	CcSEcCtD
Alfuzosin—Diarrhoea—Vinblastine—germ cell cancer	0.00353	0.00372	CcSEcCtD
Alfuzosin—Fatigue—Dactinomycin—germ cell cancer	0.0035	0.00369	CcSEcCtD
Alfuzosin—Back pain—Etoposide—germ cell cancer	0.00348	0.00367	CcSEcCtD
Alfuzosin—Hypotension—Ifosfamide—germ cell cancer	0.00348	0.00366	CcSEcCtD
Alfuzosin—Pain—Dactinomycin—germ cell cancer	0.00347	0.00366	CcSEcCtD
Alfuzosin—Urticaria—Bleomycin—germ cell cancer	0.00346	0.00364	CcSEcCtD
Alfuzosin—Dizziness—Vinblastine—germ cell cancer	0.00341	0.00359	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00339	0.00357	CcSEcCtD
Alfuzosin—Feeling abnormal—Dactinomycin—germ cell cancer	0.00334	0.00353	CcSEcCtD
Alfuzosin—Ill-defined disorder—Etoposide—germ cell cancer	0.00334	0.00352	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00332	0.0035	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00332	0.0035	CcSEcCtD
Alfuzosin—Somnolence—Ifosfamide—germ cell cancer	0.00331	0.00349	CcSEcCtD
Alfuzosin—Discomfort—Cisplatin—germ cell cancer	0.0033	0.00348	CcSEcCtD
Alfuzosin—Vomiting—Vinblastine—germ cell cancer	0.00328	0.00345	CcSEcCtD
Alfuzosin—Malaise—Etoposide—germ cell cancer	0.00325	0.00342	CcSEcCtD
Alfuzosin—Breast disorder—Methotrexate—germ cell cancer	0.00324	0.00341	CcSEcCtD
Alfuzosin—Vertigo—Etoposide—germ cell cancer	0.00323	0.00341	CcSEcCtD
Alfuzosin—Headache—Vinblastine—germ cell cancer	0.00323	0.0034	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.00322	0.0034	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00321	0.00338	CcSEcCtD
Alfuzosin—Abdominal pain—Dactinomycin—germ cell cancer	0.00321	0.00338	CcSEcCtD
Alfuzosin—Fatigue—Ifosfamide—germ cell cancer	0.00321	0.00338	CcSEcCtD
Alfuzosin—Oedema—Cisplatin—germ cell cancer	0.00321	0.00338	CcSEcCtD
Alfuzosin—Infection—Cisplatin—germ cell cancer	0.00319	0.00336	CcSEcCtD
Alfuzosin—Constipation—Ifosfamide—germ cell cancer	0.00318	0.00335	CcSEcCtD
Alfuzosin—Pain—Ifosfamide—germ cell cancer	0.00318	0.00335	CcSEcCtD
Alfuzosin—Loss of consciousness—Etoposide—germ cell cancer	0.00316	0.00333	CcSEcCtD
Alfuzosin—Nervous system disorder—Cisplatin—germ cell cancer	0.00314	0.00331	CcSEcCtD
Alfuzosin—Thrombocytopenia—Cisplatin—germ cell cancer	0.00314	0.00331	CcSEcCtD
Alfuzosin—Tachycardia—Cisplatin—germ cell cancer	0.00313	0.0033	CcSEcCtD
Alfuzosin—Asthenia—Bleomycin—germ cell cancer	0.00312	0.00329	CcSEcCtD
Alfuzosin—Skin disorder—Cisplatin—germ cell cancer	0.00311	0.00328	CcSEcCtD
Alfuzosin—Hyperhidrosis—Cisplatin—germ cell cancer	0.0031	0.00327	CcSEcCtD
Alfuzosin—Pruritus—Bleomycin—germ cell cancer	0.00308	0.00325	CcSEcCtD
Alfuzosin—Feeling abnormal—Ifosfamide—germ cell cancer	0.00307	0.00323	CcSEcCtD
Alfuzosin—Chest pain—Etoposide—germ cell cancer	0.00306	0.00323	CcSEcCtD
Alfuzosin—Nausea—Vinblastine—germ cell cancer	0.00306	0.00323	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00304	0.00321	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00304	0.00321	CcSEcCtD
Alfuzosin—Discomfort—Etoposide—germ cell cancer	0.00303	0.00319	CcSEcCtD
Alfuzosin—Hypotension—Cisplatin—germ cell cancer	0.003	0.00316	CcSEcCtD
Alfuzosin—Urticaria—Ifosfamide—germ cell cancer	0.00295	0.00311	CcSEcCtD
Alfuzosin—Abdominal pain—Ifosfamide—germ cell cancer	0.00294	0.0031	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00292	0.00308	CcSEcCtD
Alfuzosin—Infection—Etoposide—germ cell cancer	0.00292	0.00308	CcSEcCtD
Alfuzosin—Asthenia—Dactinomycin—germ cell cancer	0.00291	0.00307	CcSEcCtD
Alfuzosin—Thrombocytopenia—Etoposide—germ cell cancer	0.00288	0.00303	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00288	0.00303	CcSEcCtD
Alfuzosin—Tachycardia—Etoposide—germ cell cancer	0.00287	0.00302	CcSEcCtD
Alfuzosin—Skin disorder—Etoposide—germ cell cancer	0.00285	0.00301	CcSEcCtD
Alfuzosin—Erectile dysfunction—Methotrexate—germ cell cancer	0.00285	0.003	CcSEcCtD
Alfuzosin—Hyperhidrosis—Etoposide—germ cell cancer	0.00284	0.00299	CcSEcCtD
Alfuzosin—Diarrhoea—Dactinomycin—germ cell cancer	0.00278	0.00293	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00277	0.00292	CcSEcCtD
Alfuzosin—Vomiting—Bleomycin—germ cell cancer	0.00277	0.00292	CcSEcCtD
Alfuzosin—Infestation—Methotrexate—germ cell cancer	0.00276	0.00291	CcSEcCtD
Alfuzosin—Drowsiness—Methotrexate—germ cell cancer	0.00276	0.00291	CcSEcCtD
Alfuzosin—Infestation NOS—Methotrexate—germ cell cancer	0.00276	0.00291	CcSEcCtD
Alfuzosin—Hypotension—Etoposide—germ cell cancer	0.00275	0.00289	CcSEcCtD
Alfuzosin—Rash—Bleomycin—germ cell cancer	0.00274	0.00289	CcSEcCtD
Alfuzosin—Pain—Cisplatin—germ cell cancer	0.00274	0.00289	CcSEcCtD
Alfuzosin—Dermatitis—Bleomycin—germ cell cancer	0.00274	0.00289	CcSEcCtD
Alfuzosin—Asthenia—Ifosfamide—germ cell cancer	0.00267	0.00281	CcSEcCtD
Alfuzosin—Sweating—Methotrexate—germ cell cancer	0.00264	0.00279	CcSEcCtD
Alfuzosin—Feeling abnormal—Cisplatin—germ cell cancer	0.00264	0.00279	CcSEcCtD
Alfuzosin—Pruritus—Ifosfamide—germ cell cancer	0.00263	0.00277	CcSEcCtD
Alfuzosin—Somnolence—Etoposide—germ cell cancer	0.00261	0.00275	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Methotrexate—germ cell cancer	0.00261	0.00275	CcSEcCtD
Alfuzosin—Nausea—Bleomycin—germ cell cancer	0.00259	0.00272	CcSEcCtD
Alfuzosin—Vomiting—Dactinomycin—germ cell cancer	0.00258	0.00272	CcSEcCtD
Alfuzosin—Rash—Dactinomycin—germ cell cancer	0.00256	0.0027	CcSEcCtD
Alfuzosin—Diarrhoea—Ifosfamide—germ cell cancer	0.00254	0.00268	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Etoposide—germ cell cancer	0.00254	0.00267	CcSEcCtD
Alfuzosin—Fatigue—Etoposide—germ cell cancer	0.00253	0.00267	CcSEcCtD
Alfuzosin—Pain—Etoposide—germ cell cancer	0.00251	0.00265	CcSEcCtD
Alfuzosin—Constipation—Etoposide—germ cell cancer	0.00251	0.00265	CcSEcCtD
Alfuzosin—Dizziness—Ifosfamide—germ cell cancer	0.00246	0.00259	CcSEcCtD
Alfuzosin—Pharyngitis—Methotrexate—germ cell cancer	0.00246	0.00259	CcSEcCtD
Alfuzosin—Urinary tract disorder—Methotrexate—germ cell cancer	0.00245	0.00258	CcSEcCtD
Alfuzosin—Urethral disorder—Methotrexate—germ cell cancer	0.00243	0.00256	CcSEcCtD
Alfuzosin—Feeling abnormal—Etoposide—germ cell cancer	0.00242	0.00255	CcSEcCtD
Alfuzosin—Nausea—Dactinomycin—germ cell cancer	0.00241	0.00254	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Etoposide—germ cell cancer	0.0024	0.00253	CcSEcCtD
Alfuzosin—Vomiting—Ifosfamide—germ cell cancer	0.00236	0.00249	CcSEcCtD
Alfuzosin—Rash—Ifosfamide—germ cell cancer	0.00235	0.00247	CcSEcCtD
Alfuzosin—Dermatitis—Ifosfamide—germ cell cancer	0.00234	0.00247	CcSEcCtD
Alfuzosin—Urticaria—Etoposide—germ cell cancer	0.00233	0.00246	CcSEcCtD
Alfuzosin—Abdominal pain—Etoposide—germ cell cancer	0.00232	0.00245	CcSEcCtD
Alfuzosin—Eye disorder—Methotrexate—germ cell cancer	0.00231	0.00244	CcSEcCtD
Alfuzosin—Asthenia—Cisplatin—germ cell cancer	0.0023	0.00242	CcSEcCtD
Alfuzosin—Cardiac disorder—Methotrexate—germ cell cancer	0.0023	0.00242	CcSEcCtD
Alfuzosin—Angiopathy—Methotrexate—germ cell cancer	0.00225	0.00237	CcSEcCtD
Alfuzosin—Mediastinal disorder—Methotrexate—germ cell cancer	0.00223	0.00235	CcSEcCtD
Alfuzosin—Nausea—Ifosfamide—germ cell cancer	0.00221	0.00233	CcSEcCtD
Alfuzosin—Diarrhoea—Cisplatin—germ cell cancer	0.00219	0.00231	CcSEcCtD
Alfuzosin—Mental disorder—Methotrexate—germ cell cancer	0.00217	0.00229	CcSEcCtD
Alfuzosin—Asthenia—Etoposide—germ cell cancer	0.00211	0.00222	CcSEcCtD
Alfuzosin—Back pain—Methotrexate—germ cell cancer	0.00209	0.0022	CcSEcCtD
Alfuzosin—Pruritus—Etoposide—germ cell cancer	0.00208	0.00219	CcSEcCtD
Alfuzosin—Vomiting—Cisplatin—germ cell cancer	0.00204	0.00215	CcSEcCtD
Alfuzosin—Rash—Cisplatin—germ cell cancer	0.00202	0.00213	CcSEcCtD
Alfuzosin—Dermatitis—Cisplatin—germ cell cancer	0.00202	0.00213	CcSEcCtD
Alfuzosin—Diarrhoea—Etoposide—germ cell cancer	0.00201	0.00212	CcSEcCtD
Alfuzosin—Ill-defined disorder—Methotrexate—germ cell cancer	0.002	0.00211	CcSEcCtD
Alfuzosin—Malaise—Methotrexate—germ cell cancer	0.00194	0.00205	CcSEcCtD
Alfuzosin—Dizziness—Etoposide—germ cell cancer	0.00194	0.00205	CcSEcCtD
Alfuzosin—Vertigo—Methotrexate—germ cell cancer	0.00194	0.00204	CcSEcCtD
Alfuzosin—Nausea—Cisplatin—germ cell cancer	0.0019	0.00201	CcSEcCtD
Alfuzosin—Vomiting—Etoposide—germ cell cancer	0.00187	0.00197	CcSEcCtD
Alfuzosin—Rash—Etoposide—germ cell cancer	0.00185	0.00195	CcSEcCtD
Alfuzosin—Dermatitis—Etoposide—germ cell cancer	0.00185	0.00195	CcSEcCtD
Alfuzosin—Headache—Etoposide—germ cell cancer	0.00184	0.00194	CcSEcCtD
Alfuzosin—Chest pain—Methotrexate—germ cell cancer	0.00184	0.00193	CcSEcCtD
Alfuzosin—Arthralgia—Methotrexate—germ cell cancer	0.00184	0.00193	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00182	0.00192	CcSEcCtD
Alfuzosin—Discomfort—Methotrexate—germ cell cancer	0.00181	0.00191	CcSEcCtD
Alfuzosin—Infection—Methotrexate—germ cell cancer	0.00175	0.00184	CcSEcCtD
Alfuzosin—Nausea—Etoposide—germ cell cancer	0.00174	0.00184	CcSEcCtD
Alfuzosin—Nervous system disorder—Methotrexate—germ cell cancer	0.00173	0.00182	CcSEcCtD
Alfuzosin—Thrombocytopenia—Methotrexate—germ cell cancer	0.00172	0.00182	CcSEcCtD
Alfuzosin—Skin disorder—Methotrexate—germ cell cancer	0.00171	0.0018	CcSEcCtD
Alfuzosin—Hyperhidrosis—Methotrexate—germ cell cancer	0.0017	0.00179	CcSEcCtD
Alfuzosin—Hypotension—Methotrexate—germ cell cancer	0.00164	0.00173	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.0016	0.00169	CcSEcCtD
Alfuzosin—Somnolence—Methotrexate—germ cell cancer	0.00156	0.00165	CcSEcCtD
Alfuzosin—Dyspepsia—Methotrexate—germ cell cancer	0.00155	0.00163	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.00152	0.0016	CcSEcCtD
Alfuzosin—Fatigue—Methotrexate—germ cell cancer	0.00152	0.0016	CcSEcCtD
Alfuzosin—Pain—Methotrexate—germ cell cancer	0.0015	0.00159	CcSEcCtD
Alfuzosin—Feeling abnormal—Methotrexate—germ cell cancer	0.00145	0.00153	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00144	0.00152	CcSEcCtD
Alfuzosin—Urticaria—Methotrexate—germ cell cancer	0.0014	0.00147	CcSEcCtD
Alfuzosin—Abdominal pain—Methotrexate—germ cell cancer	0.00139	0.00147	CcSEcCtD
Alfuzosin—Asthenia—Methotrexate—germ cell cancer	0.00126	0.00133	CcSEcCtD
Alfuzosin—Pruritus—Methotrexate—germ cell cancer	0.00124	0.00131	CcSEcCtD
Alfuzosin—Diarrhoea—Methotrexate—germ cell cancer	0.0012	0.00127	CcSEcCtD
Alfuzosin—Dizziness—Methotrexate—germ cell cancer	0.00116	0.00123	CcSEcCtD
Alfuzosin—Vomiting—Methotrexate—germ cell cancer	0.00112	0.00118	CcSEcCtD
Alfuzosin—Rash—Methotrexate—germ cell cancer	0.00111	0.00117	CcSEcCtD
Alfuzosin—Dermatitis—Methotrexate—germ cell cancer	0.00111	0.00117	CcSEcCtD
Alfuzosin—Headache—Methotrexate—germ cell cancer	0.0011	0.00116	CcSEcCtD
Alfuzosin—Nausea—Methotrexate—germ cell cancer	0.00105	0.0011	CcSEcCtD
